Every SEC Form 3/4/5 on record for this filer (CIK 1616230) — 3 issuers, 25 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Director | 2015-08-13 → 2026-06-15 | 21 | −$1M |
| CNST | CONSTELLATION PHARMACEUTICALS INC | Chief Medical Officer · lapsed | 2018-07-18 → 2020-05-13 | 7 | −$1M |
| CERU | Cerulean Pharma Inc. | SVP, Chief Medical Officer · lapsed | 2015-12-03 → 2017-01-09 | 6 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PBYI | 2026-06-12 | Sell | 27,000 | $7.20 | $194,400 | 27,000 |
| PBYI | 2025-06-13 | Sell | 27,000 | $3.40 | $91,800 | 27,000 |
| PBYI | 2024-06-13 | Sell | 27,000 | $3.33 | $89,910 | — |
| PBYI | 2023-06-13 | Sell | 27,000 | $3.45 | $93,150 | — |
| PBYI | 2022-06-16 | Sell | 27,858 | $2.63 | $73,267 | 27,000 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
